vidgastech

Ruxolitinib is a well-known JAK1/JAK2 inhibitor widely used in the treatment of myelofibrosis and other inflammatory conditions. The synthesis of Ruxolitinib requires several high-quality chemical intermediates, among which 1-(1-ethoxyethyl)-4-iodo-1H-pyrazole (CAS No. 575452-22-1) plays a crucial role. VidgasTech specializes in supplying premium Ruxolitinib intermediates to support pharmaceutical manufacturing, research laboratories, and chemical production units worldwide.